KANJINTI Trademark

Trademark Overview

On Tuesday, August 30, 2016, a trademark application was filed for KANJINTI with the United States Patent and Trademark Office. The USPTO has given the KANJINTI trademark a serial number of 87155764. The federal status of this trademark filing is REGISTERED as of Tuesday, October 8, 2019. This trademark is owned by Amgen Inc.. The KANJINTI trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations used for the treatment of cancer; pharmaceutical preparations, namely, biosimilars used for the treatment of cancer; pharmaceutical preparations and biosimilars used for the treatment of breast and gastric disorders and diseases
kanjinti

General Information

Serial Number87155764
Word MarkKANJINTI
Filing DateTuesday, August 30, 2016
Status700 - REGISTERED
Status DateTuesday, October 8, 2019
Registration Number5880416
Registration DateTuesday, October 8, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 17, 2017

Trademark Statements

Goods and Servicespharmaceutical preparations used for the treatment of cancer; pharmaceutical preparations, namely, biosimilars used for the treatment of cancer; pharmaceutical preparations and biosimilars used for the treatment of breast and gastric disorders and diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 6, 2016
Primary Code005
First Use Anywhere DateFriday, July 19, 2019
First Use In Commerce DateFriday, July 19, 2019

Trademark Owner History

Party NameAmgen Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799
Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799
Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Trademark Events

Event DateEvent Description
Tuesday, October 8, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, September 4, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 3, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 3, 2019STATEMENT OF USE PROCESSING COMPLETE
Wednesday, August 28, 2019USE AMENDMENT FILED
Wednesday, August 28, 2019TEAS STATEMENT OF USE RECEIVED
Friday, May 31, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 30, 2019EXTENSION 5 GRANTED
Friday, May 24, 2019EXTENSION 5 FILED
Thursday, May 30, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 24, 2019TEAS EXTENSION RECEIVED
Tuesday, March 12, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 8, 2019EXTENSION 4 GRANTED
Friday, March 8, 2019EXTENSION 4 FILED
Friday, March 8, 2019TEAS EXTENSION RECEIVED
Thursday, March 7, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 7, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 29, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 27, 2018EXTENSION 3 GRANTED
Monday, August 27, 2018EXTENSION 3 FILED
Monday, August 27, 2018TEAS EXTENSION RECEIVED
Thursday, August 2, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 2, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, March 3, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 1, 2018EXTENSION 2 GRANTED
Thursday, March 1, 2018EXTENSION 2 FILED
Thursday, March 1, 2018TEAS EXTENSION RECEIVED
Thursday, August 24, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 22, 2017EXTENSION 1 GRANTED
Tuesday, August 22, 2017EXTENSION 1 FILED
Tuesday, August 22, 2017TEAS EXTENSION RECEIVED
Tuesday, March 14, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 17, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 17, 2017PUBLISHED FOR OPPOSITION
Wednesday, December 28, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, December 12, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Sunday, December 4, 2016ASSIGNED TO LIE
Tuesday, November 22, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 22, 2016EXAMINER'S AMENDMENT ENTERED
Tuesday, November 22, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 22, 2016EXAMINERS AMENDMENT E-MAILED
Tuesday, November 22, 2016EXAMINERS AMENDMENT -WRITTEN
Friday, October 28, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 28, 2016NON-FINAL ACTION E-MAILED
Friday, October 28, 2016NON-FINAL ACTION WRITTEN
Friday, October 28, 2016ASSIGNED TO EXAMINER
Tuesday, September 6, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, September 2, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

kanjinti pharmaceutical used treatment preparations biosimilars cancer diseases disorders namely breast